Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Divide and Rule: Companies File ‘Divisional’ Applications to Avoid Oppositions Against HIV Drug Patents
Divisional or Continuation Application? Abbott Re-Files the Same Application
Update India: Abbott Files a Divisional Application for its Heat Stable Ritonavir/Lopinavir Formulation
Brazil’s Attorney General Challenges Constitutionality of “Pipeline” Protection in Patent Law
I-MAK’s Director of Treatment Access Awarded Fellowship in 2009 Class of Asia 21 Young Leaders
Challenging Patents for Patients
Enforcement, Creative R&D Financing Priority Issues for Public Health in 2009 – by Kaitlin Mara of IP Watch
Echoing Green’s Featured 2008 Fellows
I-MAK working towards improving drug access
Dgoodr.com